These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The lesson of the practolol drama; can adverse effects of drugs be recognized as such sooner?]. Offerhaus L Ned Tijdschr Geneeskd; 1978 Nov; 122(44):1709-12. PubMed ID: 360080 [No Abstract] [Full Text] [Related]
4. Clinical trials in oncology: ethics, errors, methods and results. Proceedings of an international symposium. Villejuif, France, 25-29 June 1984. Drugs Exp Clin Res; 1986; 12(1-3):1-298. PubMed ID: 3732045 [No Abstract] [Full Text] [Related]
5. Clinical drug trials. An appraisal of presentations in two medical journals. Hill AJ N S Med Bull; 1970 Feb; 49(1):12-3. PubMed ID: 4904522 [No Abstract] [Full Text] [Related]
6. Who has the ultimate responsible for publishing clinical research results? Wilde H; Sitprija V J Med Assoc Thai; 2001 Aug; 84(8):1217-20. PubMed ID: 11758861 [No Abstract] [Full Text] [Related]
7. [Clinical therapeutic trials: introduction to the topic]. Buchborn E Internist (Berl); 1982 Apr; 23(4):183-6. PubMed ID: 7045019 [No Abstract] [Full Text] [Related]
8. Phase 0 trials: are they ethically challenged? Hill TP Clin Cancer Res; 2007 Feb; 13(3):783-4. PubMed ID: 17289866 [No Abstract] [Full Text] [Related]
9. Drug trials in general practice. Drug Ther Bull; 1981 Dec; 19(25):97-9. PubMed ID: 7297426 [No Abstract] [Full Text] [Related]
13. Open access to trials register. McCabe S PLoS Med; 2005 Feb; 2(2):e49. PubMed ID: 15737004 [No Abstract] [Full Text] [Related]
14. [Are children in the shadow region of drug therapy]. Hämäläinen M Duodecim; 2001; 117(18):1781-2. PubMed ID: 12181973 [No Abstract] [Full Text] [Related]
15. Michigan regional drug information network. IV. Description and evaluation. Pearson RE; Thudium VF; Phillips GL Am J Hosp Pharm; 1972 Apr; 29(4):312-20. PubMed ID: 5025261 [No Abstract] [Full Text] [Related]
17. [Task and execution method of an ethics committee with the example of the Tubingen Ethics Committee]. Malchow H; Bierich J; Eser A; Roemer VM; Rössler D Internist (Berl); 1982 Apr; 23(4):227-32. PubMed ID: 7045025 [No Abstract] [Full Text] [Related]
18. [Pharmacologic surveillance outside the hospital: necessity and methods]. Cuena R; Honorato J; Azanza JR; Suárez JR; Rubio A Rev Med Univ Navarra; 1987; 31(3):163-6. PubMed ID: 3507792 [No Abstract] [Full Text] [Related]
19. [Moral problems and responsibility of the physician during therapeutic trials]. Caroff J Therapie; 1971; 26(6):1107-22. PubMed ID: 4947772 [No Abstract] [Full Text] [Related]
20. Guidelines for monitoring efficacy and toxicity responses in clinical trials. Cook RJ; Farewell VT Biometrics; 1994 Dec; 50(4):1146-52. PubMed ID: 7786995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]